Waddell C C, Cimo P L
Am J Hematol. 1979;7(4):381-7. doi: 10.1002/ajh.2830070410.
The occurrence of idiopathic thrombocytopenic purpura (ITP) in Hodgkin disease is uncommon. Even more unusual is the development of ITP in Hodgkin disease following splenectomy. This report describes two patients with Hodgkin disease who developed severe ITP with negative platelet antibody studies very soon after splenectomy (20 days in one and three months in the other). A review of the literature of 21 other patients with well-documented ITP and Hodgkin disease indicated that ITP occurring in Hodgkin disease may be more severe and refractory to therapy than ITP unassociated with Hodgkin. Nodular sclerosis or mixed cellularity histologic types of Hodgkin disease were present in all but one of the patients with ITP and Hodgkin disease, and males constituted 65% of cases. There appeared to be no correlation between the onset of ITP and activity of Hodgkin disease. Of five splenectomized patients with Hodgkin disease who developed ITP and were treated with immunosuppressive drugs for thrombocytopenia, three had an excellent response and two had a good response, suggesting that the combination of corticosteroids and immunosuppressive drugs may be indicated at the outset in patients with Hodgkin disease who develop ITP following splenectomy.
霍奇金病患者发生特发性血小板减少性紫癜(ITP)并不常见。更罕见的是,霍奇金病患者在脾切除术后发生ITP。本报告描述了两名霍奇金病患者,他们在脾切除术后很快(一例为20天,另一例为三个月)就出现了严重的ITP,血小板抗体研究呈阴性。对另外21例有充分记录的ITP合并霍奇金病患者的文献回顾表明,霍奇金病中发生的ITP可能比与霍奇金病无关的ITP更严重且对治疗更具难治性。除1例患者外,所有ITP合并霍奇金病的患者均为结节硬化型或混合细胞型组织学类型的霍奇金病,男性占病例的65%。ITP的发病与霍奇金病的活动之间似乎没有相关性。在5例脾切除术后发生ITP并接受免疫抑制药物治疗血小板减少症的霍奇金病患者中,3例反应良好,2例反应尚可,这表明对于脾切除术后发生ITP的霍奇金病患者,一开始就可能需要使用皮质类固醇和免疫抑制药物联合治疗。